Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Molecular Pharmaceutics|October 3, 2006
Cationic poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to ratsBen J Boyd, Lisa M Kaminskas, Peter Karellas, et al.
Nano Letters|September 24, 2009
Nanoscale arrangement of apoptotic ligands reveals a demand for a minimal lateral distance for efficient death receptor activationJulia Ranzinger, Anja Krippner-Heidenreich, Tamas Haraszti, et al.
The Biochemical Journal|September 6, 2001
Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1A Krippner-Heidenreich, R V Talanian, R Sekul, et al.
Psychology & Health|January 22, 2024
Protecting mass-gathering events in a pandemic with testing tracks and transparent information: an experimental study with festival guestsFelix G Rebitschek, Yvonne Eisenmann, Lena Krippner, et al.
Frontiers in Immunology|March 8, 2021
Platelets in Multiple Sclerosis: Early and Central Mediators of Inflammation and Neurodegeneration and Attractive Targets for Molecular Imaging and Site-Directed TherapyJacqueline M Orian, Claretta S D'Souza, Pece Kocovski, et al.
Acta Crystallographica. Section D, Biological Crystallography|December 6, 2014
The structure of vanin 1: a key enzyme linking metabolic disease and inflammationYkelien L Boersma, Janet Newman, Timothy E Adams, et al.
Free Radical Biology & Medicine|January 30, 2018
Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosisAnja Jelinek, Lukas Heyder, Michael Daude, et al.
EMBO Reports|September 22, 2020
Postmitotic expansion of cell nuclei requires nuclear actin filament bundling by α-actinin 4Sylvia Krippner, Jannik Winkelmeier, Julian Knerr, et al.
Diabetes|November 15, 2018
Targeting the CDA1/CDA1BP1 Axis Retards Renal Fibrosis in Experimental Diabetic NephropathyZhonglin Chai, Tieqiao Wu, Aozhi Dai, et al.
Journal of Pharmaceutical Sciences|March 14, 2009
Partly-PEGylated Poly-L-lysine dendrimers have reduced plasma stability and circulation times compared with fully PEGylated dendrimersL M Kaminskas, Z Wu, N Barlow, et al.
Pageof 12